Medicare & Medicaid


For registered hospital inpatients and/or outpatients that have  Medicare coverage, Athena will bill the hospital directly. For all other  Medicare patients, Athena Diagnostics will submit claims to Medicare Part B (in Massachusetts) for all of our non-molecular tests. Patients with Medicare Part B are not responsible for any payment for non-molecular tests.  A signed and completed Advance Beneficiary Notice (ABN) is required for molecular tests, as Medicare may not cover molecular testing. 

Medicare Advantage

Athena will file claims with the patient’s health plan. The patient will be held liable for any balance due as indicated on the Explanation of Benefits (EOB).  If the patient responsibility is more than $250.00 the patient may qualify for financial assistance. 


Athena Diagnostics is not a participating provider in any Medicaid program.  Medicaid patients may qualify for financial assistance. 

Uninsured or Self-Pay PatientsAthena Diagnostics offers a discount to patients who are uninsured or who wish to pay out-of-pocket. For specific details, please see the Athena Alliance Program above.

About Athena

Athena Diagnostics is a leader in diagnostic testing for neurological diseases and offers innovative tests for Alzheimer's disease, muscular dystrophy and other neuromuscular and developmental disorders.

View Full Catalog

About Us

Accreditations and Licensing

Patents Held


Contact Us

Athena Diagnostics, Inc.
200 Forest Street, 2nd Floor
Marlborough, MA 01752

(508) 756-2886

Copyright © 2018 Athena Diagnostics, Inc.
All trademarks and service marks identified by ®, ™ or ℠ symbols or appearing in type form different from that of the surrounding text are marks owned by or licensed to Athena Diagnostics, Inc., its subsidiaries or affiliates, unless otherwise identified as being owned by another entity. See Full Notice